VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 733 filers reported holding VANECK VECTORS ETF TR in Q2 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,621 | -10.6% | 2,550 | 0.0% | 0.11% | -3.6% |
| Q2 2023 | $76,781 | -6.9% | 2,550 | 0.0% | 0.11% | -7.5% |
| Q1 2023 | $82,493 | +17.5% | 2,550 | +4.1% | 0.12% | +25.0% |
| Q4 2022 | $70,217 | +13.3% | 2,450 | -5.0% | 0.10% | +35.2% |
| Q3 2022 | $62,000 | -68.8% | 2,580 | -64.6% | 0.07% | -66.0% |
| Q2 2022 | $199,000 | -39.5% | 7,280 | -15.2% | 0.21% | -32.4% |
| Q1 2022 | $329,000 | +17.1% | 8,580 | -2.3% | 0.31% | +40.5% |
| Q4 2021 | $281,000 | +7.7% | 8,780 | -0.9% | 0.22% | +3.3% |
| Q3 2021 | $261,000 | -21.4% | 8,860 | -9.2% | 0.21% | -17.1% |
| Q2 2010 | $332,000 | – | 9,760 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |